Knowledge Center

Article / Jan 01, 2011

What is Special About Inhalation APIs?

Authors:
  • Carla Vozone
Source:
Drug Development and Delivery, January 2011

What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for ËÄÉ«AV's Generics Business Unit, discusses what makes ËÄÉ«AV unique in API supply for inhalation, its supportive technologies, and approach to the market.

Related links

Also in the Knowledge Center

Related Content

Drug delivery platforms

ËÄÉ«AV has unique capabilities and expertise in solubility enhancement, lung delivery, modified release and taste-masking applications.

Page
Read more

¶Ù¾±²õ±è±ð°ù²õ´Ç³¾±ð®

Make your drug soluble with ¶Ù¾±²õ±è±ð°ù²õ´Ç³¾±ð® technology. ¶Ù¾±²õ±è±ð°ù²õ´Ç³¾±ð® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.

Page
Read more

Development by Design

Development by Design is ËÄÉ«AV’s proven spray-dried dispersion scale-up and tech-transfer methodology.

Page
Read more